W. Garvey to Cardiovascular Diseases
This is a "connection" page, showing publications W. Garvey has written about Cardiovascular Diseases.
Connection Strength
4.574
-
Examining the evidence for weight management in individuals with type 2 diabetes. Diabetes Obes Metab. 2022 08; 24(8):1411-1422.
Score: 0.467
-
Associations between cardiometabolic disease severity, social determinants of health (SDoH), and poor COVID-19 outcomes. Obesity (Silver Spring). 2022 07; 30(7):1483-1494.
Score: 0.467
-
Arterial Stiffness: Comment on the Article by Pavloska et?al. Endocr Pract. 2021 06; 27(6):640-641.
Score: 0.433
-
Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 02 11; 75(5):525-538.
Score: 0.399
-
Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 02 11; 75(5):539-555.
Score: 0.399
-
Obesity: Obesity and cardiometabolic disease - more than meets the eye. Nat Rev Endocrinol. 2017 10; 13(10):566-568.
Score: 0.336
-
The Adipokine-Cardiovascular-Lifestyle Network: Translation to Clinical Practice. J Am Coll Cardiol. 2016 10 18; 68(16):1785-1803.
Score: 0.317
-
Trends in Cardiovascular Health Metrics in Obese Adults: National Health and Nutrition Examination Survey (NHANES), 1988-2014. J Am Heart Assoc. 2016 07 13; 5(7).
Score: 0.311
-
The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity. Obesity (Silver Spring). 2014 Jan; 22(1):110-8.
Score: 0.255
-
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012 Feb; 95(2):297-308.
Score: 0.226
-
Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol. 2007 Jun; 18(3):263-70.
Score: 0.165
-
Household disorder and blood pressure in mother-child dyads: A brief report. J Fam Psychol. 2023 Mar; 37(2):256-261.
Score: 0.119
-
Race Versus Social Determinants of Health in COVID-19 Hospitalization Prediction. Am J Prev Med. 2022 07; 63(1 Suppl 1):S103-S108.
Score: 0.118
-
Case presentation and panel discussion: Cardiometabolic risk mitigation. JPEN J Parenter Enteral Nutr. 2021 11; 45(S2):93-99.
Score: 0.112
-
Serum urate and cardiovascular events in the DCCT/EDIC study. Sci Rep. 2021 07 09; 11(1):14182.
Score: 0.110
-
Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D. J Lipid Res. 2019 08; 60(8):1432-1439.
Score: 0.095
-
APPLICATION OF THE AACE/ACE ADVANCED FRAMEWORK FOR THE DIAGNOSIS OF OBESITY AND CARDIOMETABOLIC DISEASE STAGING IN A GENERAL POPULATION FROM 3 REGIONS OF VENEZUELA: THE VEMSOLS STUDY RESULTS. Endocr Pract. 2018 Jan; 24(1):6-13.
Score: 0.085
-
Cardiovascular risk in Gullah African Americans with high familial risk of type 2 diabetes mellitus: project SuGAR. South Med J. 2014 Oct; 107(10):607-14.
Score: 0.069
-
Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care. 2004 Apr; 27(4):978-83.
Score: 0.033
-
Short-term impact of a church-based approach to lifestyle change on cardiovascular risk in African Americans. Ethn Dis. 2000; 10(1):17-23.
Score: 0.025
-
AACE/ACE comprehensive diabetes management algorithm 2015. Endocr Pract. 2015 Apr; 21(4):438-47.
Score: 0.018
-
AACE comprehensive diabetes management algorithm 2013. Endocr Pract. 2013 Mar-Apr; 19(2):327-36.
Score: 0.015